Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 28 August 2026.

Announcements

6,191

Total raised

£161B

disclosed amounts

This month

£621M

raised so far

Growth
£10.4M

SmartSearch has received a growth equity investment from Marlin Equity Partners to scale its compliance platform.

"We first met Marlin through an investment process we ran to find a partner; the high degree of interest in our business impressed everyone and Marlin stood out from the crowd. It was clear from our first meeting that Marlin has a deep understanding of our sector, our business model and they had done their homework. They quickly demonstrated how they could add value to our business, and we had a strong meeting of minds with a common goal."
— John Dobson, CEO
Pre-Seed
£1.0M

The funding was led by Joe Saumarez Smith to support the expansion of the Alvius platform.

"Now employers can use our software to create their own talent platforms, replacing slow and inefficient sourcing and selection processes and matching great talent with current opportunities in a fraction of the time."
— Andrew Lavelle, co-founder of TalentPool and Alvius managing director
Debt
£45.0K

The ethical skincare maker will use the loan from the Development Bank of Wales to scale up its manufacturing capabilities.

"Firstly I createdtwo products to help with my son’s appalling sensitive skin. I created a cold processed soap, and an oil called Soothe. These have won three national awards between them. I have since gone on to create over 30 products, each one designed to serve a purpose. We have grown from my kitchen table, selling directly to the public at farmers markets to supplying organisations like CADW and The Royal Horticultural Society. We have around 150 independent stockists."
— George Jones, Founder
Series A
£2.8M

The funding round was led by Mercia to support pre-clinical testing and manufacturing as the company prepares for clinical trials.

"Our goal is to bring much-needed improvement to the lives of three million dialysis patients. This investment allows us to take a big step towards this, and we are delighted to have won the backing of a consortium of smart, well-funded investors."
— Richard Boyd, CEO